Featured Research

from universities, journals, and other organizations

Into adulthood, sickle cell patients rely on ER

Date:
December 10, 2012
Source:
Washington University in St. Louis
Summary:
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers.

Moving from childhood to adulthood, patients with sickle cell disease rely more on emergency care, according to a new study from Washington University School of Medicine in St. Louis. Normal red blood cells (top) are round and disk-like. The genetic disorder causes many red blood cells to develop an abnormal sickle shape (bottom), making it hard for blood to flow through vessels and carry oxygen to the body. The condition can cause debilitating pain, blindness, strokes and pneumonia.
Credit: Morey A. Blinder, M.D.

Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.

An analysis of Medicaid data of more than 3,200 patients with sickle cell disease shows that emergency room visits tripled from age 15 to age 24. The research is reported Dec. 10 at the American Society of Hematology's annual meeting, in Atlanta.

"There seems to be a breakdown in medical care during the transition from childhood to adulthood," says hematologist Morey A. Blinder, MD, associate professor of medicine. "Not only emergency department usage, but hospitalizations go up during this time as well."

One possible explanation for the increased reliance on emergency care, according to Blinder, is the relative lack of adult health care providers with experience caring for sickle cell patients. Similar issues are arising for other pediatric diseases, such as cystic fibrosis and hemophilia, which were previously fatal. Over the past few decades, an increasing number of children and teenagers are living into adulthood with these conditions and there often aren't enough primary care physicians who can provide care for these adult patients.

Sickle cell disease refers to a number of inherited genetic conditions that cause the normally round, disk-like red blood cells to take on a characteristic "sickle" shape. These malformed red blood cells do not carry oxygen to the body as well as healthy cells and are prone to clogging smaller blood vessels. The condition is often painful in places the cells block blood flow. Some of the more severe complications include blindness, strokes and pneumonia.

In the study, researchers examined data of 3,200 Medicaid patients with sickle cell disease from the mid 1990s through 2010. The researchers followed patients from five states (Florida, New Jersey, Missouri, Iowa and Kansas) for an average of six years each and included those moving from pediatric to adult care.

The study showed that emergency department visits tripled over nine years, increasing from 0.76 per quarter at age 15 to more than two per quarter at age 24. At age 36, use of emergency care peaked at almost three visits per quarter, or about one per month. Even by age 50, reliance on emergency care did not return to the lower levels seen in childhood.

More emergency care and hospitalizations also result in higher overall medical costs. Total health care costs were more than $7,000 higher per quarter for patients making heavier use of the emergency department, even as they tended to spend less on medication, perhaps simply failing to fill prescriptions.

Blinder says the St. Louis region and Missouri in general have good support for adults with sickle cell disease, though this is not always the case nationally.

"In areas without good adult support for this disease, you have to identify adult physicians who would be interested in treating sickle cell patients," Blinder says. "They could be hematologists or even internists, but in general there are not enough providers for adult sickle cell patients.

"This study highlights an emerging problem in transitioning pediatric age patients to adulthood, and the need to explore new ways to facilitate that process," Blinder says.

The study was funded by Novartis Pharmaceuticals. Blinder is a consultant for Novartis and receives some research support from the company. Several of the study's co-investigators are employed by Novartis.


Story Source:

The above story is based on materials provided by Washington University in St. Louis. The original article was written by Julia Evangelou Strait. Note: Materials may be edited for content and length.


Cite This Page:

Washington University in St. Louis. "Into adulthood, sickle cell patients rely on ER." ScienceDaily. ScienceDaily, 10 December 2012. <www.sciencedaily.com/releases/2012/12/121210112127.htm>.
Washington University in St. Louis. (2012, December 10). Into adulthood, sickle cell patients rely on ER. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/12/121210112127.htm
Washington University in St. Louis. "Into adulthood, sickle cell patients rely on ER." ScienceDaily. www.sciencedaily.com/releases/2012/12/121210112127.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins